Kimberly-Clark Co. (NYSE:KMB - Get Free Report) has received a consensus rating of "Hold" from the thirteen ratings firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $145.08.
KMB has been the topic of several analyst reports. Piper Sandler lowered their target price on shares of Kimberly-Clark from $158.00 to $156.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Royal Bank of Canada reduced their price target on shares of Kimberly-Clark from $165.00 to $162.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Barclays reduced their price target on shares of Kimberly-Clark from $139.00 to $135.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 24th. JPMorgan Chase & Co. upped their price target on shares of Kimberly-Clark from $124.00 to $131.00 and gave the stock an "underweight" rating in a research report on Friday, April 11th. Finally, Wells Fargo & Company upped their price target on shares of Kimberly-Clark from $130.00 to $140.00 and gave the stock an "equal weight" rating in a research report on Friday, March 28th.
Check Out Our Latest Report on KMB
Insider Transactions at Kimberly-Clark
In related news, insider Katy Chen sold 740 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $129.70, for a total transaction of $95,978.00. Following the sale, the insider now directly owns 3,997 shares of the company's stock, valued at $518,410.90. This trade represents a 15.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Andrew Drexler sold 2,500 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $140.00, for a total transaction of $350,000.00. Following the transaction, the vice president now owns 2,553 shares in the company, valued at approximately $357,420. This trade represents a 49.48% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,872 shares of company stock valued at $2,208,684. Company insiders own 0.64% of the company's stock.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in shares of Kimberly-Clark by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 35,142,545 shares of the company's stock worth $4,605,079,000 after purchasing an additional 4,603,787 shares during the period. Norges Bank purchased a new position in shares of Kimberly-Clark during the fourth quarter valued at $582,592,000. GAMMA Investing LLC increased its holdings in Kimberly-Clark by 10,975.8% during the first quarter. GAMMA Investing LLC now owns 1,902,050 shares of the company's stock valued at $270,510,000 after buying an additional 1,884,877 shares during the period. Pacer Advisors Inc. raised its holdings in Kimberly-Clark by 2,982.8% in the first quarter. Pacer Advisors Inc. now owns 1,384,318 shares of the company's stock worth $196,878,000 after purchasing an additional 1,339,413 shares in the last quarter. Finally, First Trust Advisors LP boosted its stake in Kimberly-Clark by 163.1% in the fourth quarter. First Trust Advisors LP now owns 2,142,749 shares of the company's stock valued at $280,786,000 after acquiring an additional 1,328,341 shares in the last quarter. 76.29% of the stock is currently owned by institutional investors.
Kimberly-Clark Trading Up 1.4%
Shares of Kimberly-Clark stock opened at $139.33 on Monday. The firm has a market capitalization of $46.23 billion, a PE ratio of 18.45, a price-to-earnings-growth ratio of 4.46 and a beta of 0.35. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.80 and a quick ratio of 0.54. The company's fifty day moving average price is $137.09 and its two-hundred day moving average price is $134.75. Kimberly-Clark has a 52-week low of $124.10 and a 52-week high of $150.45.
Kimberly-Clark (NYSE:KMB - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.04. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the prior year, the firm earned $2.01 EPS. On average, analysts expect that Kimberly-Clark will post 7.5 EPS for the current year.
Kimberly-Clark Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 2nd. Stockholders of record on Friday, June 6th will be given a $1.26 dividend. The ex-dividend date of this dividend is Friday, June 6th. This represents a $5.04 dividend on an annualized basis and a dividend yield of 3.62%. Kimberly-Clark's dividend payout ratio is currently 68.66%.
About Kimberly-Clark
(
Get Free ReportKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report